become re-established as a significant sexually transmitted disease in the United States' and outbreaks have sporadically occurred in other temperate regions.6" In many areas where the disease is endemic, chancroid remains a purely clinical diagnosis because Gram stained smears made from the exudate obtained from ulcerations are unreliable' and isolation of the causative bacterium, H. ducreyi, is difficult because the organisms are fastidious and the media required for primary isolation expensive. By using a single enriched selective medium and optimal cultural conditions the isolation rate of H. ducreyi from presumptive chancroidal ulcerations has been estimated to be 60-70%, with higher rates being achieved iftwo media are employed.' Clearly there remains a need for a simple, specific and sensitive test for the diagnosis of the disease. Similar difficulties have been encountered in establishing a diagnosis in two other sexually transmitted diseases, namely, chlamydial infection and genital herpes. Demonstration of these organisms by noncultural methods has been achieved by the development of monoclonal antibodies to Chlamydia trachomatis and HSV-2, and their subsequent use in the detection of specific antigens in clinical smears.""t Monoclonal antibodies to H. ducreyi have previously been used to detect these organisms in ulcer material obtained from experimental animals using a radio-immunoblotting technique'2 and in a limited number of clinical cases using immunofluorescence. '3 We have raised similar monoclonal antibodies--to H. ducreyi which react with a single polypeptide band (MW 29,000 kd), in the outer membrane protein ofthe bacterium (Finn et al. J Med Microbiol. In press).
In this communication we further describe the use of one of these monoclonal antibodies in the diagnosis of the disease, by comparing the results of immunofluorescence staining with those obtained using culture. 
Materials and methods
Bacterial strain H. ducreyi strain 3138, originally isolated from a case ofchancroid in Kenya was kindly provided by Professor P Piot, Institute of Tropical Medicine, Antwerp, Belgium. This strain was used as the immunogen in the production of monoclonal antibodies and was maintained on medium comprising Mueller-Hinton agar base (BBL), 5% chocolated horse blood (Oxoid), 5% foetal calf serum (Gibco), 2% IsoVitaleX (BBL) and 3 mg/l vancomycin in an atmosphere containing 10% CO2 at high humidity for 48 hours.
Immunisation of mice and production of monoclonal antibodies Eight week old Balb/C mice were bled immediately prior to being immunised subcutaneously with 0-2 ml of 10' cfu/ml of H. ducreyi strain 3138 suspended in Freunds' incomplete adjuvant. They were injected with a further 0-2ml of antigen in saline intraperitoneally on day 28, and intravenously on day 31. Three days later the mice were killed, their spleens removed and spleen cell suspensions prepared and fused with NSO myeloma cells using the technique ofKohler and Milstein.'3 The supernatants of the resulting hybrid cultures were screened for antibody using indirect immunofluorescence and a dot-blot technique. Antibody-producing hybridomas were isolated and cloned by passage through five limiting dilutions. Three cell lines showing highly reactive antibody were expanded. The antibodies were purified through protein-A-sepharose columns (Sigma), characterised and stored in aliquots at -70°C. Of 34 specimens of bubo material obtained in Bangkok, nine were found to be H. ducreyi-positive by culture (26%). Of these, eight were also positive by immunofluorescence. Of those 25 specimens found to be H. ducreyi culture-negative, 11 were positive by immunofluorescence. Using culture as the denominator, immunofluorescence had a sensitivity of93%, a specificity of 63%, a positive predictive value (PPV) of 82% and a negative predictive value (NPV) of83% for primary ulcerations seen in Johannesburg. The test also had a sensitivity of 89%, a specificity of 56%, a PPV of 42% and NPV of 93% for the bubo study undertaken in Bangkok.
However, this presupposes that culture is in fact the "gold standard" for the diagnosis ofchancroid. In this study we 
Discussion
At present, despite a recognised lack of sensitivity, culture of H. ducreyi is considered the method of choice for the diagnosis of chancroid and has largely superseded the use of Gram stained smears, intradermal skin tests and the establishment of a diagnosis on purely clinical grounds. However, it is generally accepted that even under ideal conditions when two selective media are used, culture has a sensitivity of only 80%.9 This lack of sensitivity of the existing culture techniques highlights the need for a simple, sensitive, non-culture test which could be employed to establish a deffnitive diagnosis in individual cases of genital ulcer disease.
The results obtained in this study indicate that since fewer negative results were obtained by immunofluorescence than by culture, the monoclonal antibody technique is either more sensitive than isolation of H. ducreyi or has a high rate of false positivity. The results of preliminary experiments on simulated clinical specimens clearly indicate that the immunofluorescence technique is far more sensitive than culture to the extent that the test is theoretically capable of detecting a single bacterium, but that culture-positivity can only be assured when approximately four bacteria are present in the inoculum.
Further evidence to suggest that immunofluorescence is more sensitive than culture was obtained by the use of the murine model. Thus, only 34 of 238 specimens (14%) were positive by culture compared with 69 of 73 (95%) which were positive by immunofluorescence. These findings would appear to indicate that the vast majority of bacteria detected after intradermal inoculation of H. ducreyi in mice were non-viable and that the immunofluorescence test is capable of detecting both viable and non-viable bacteria. Indeed, heat-killed H. ducreyiinoculated into mouse skin has subsequently been detected by the immunofluorescence technique (M Tuffrey, CRC, Harrow, Middlesex, personal communication).
In the clinical studies reported here, many more positives were obtained using immunofluorescence than by culture, a finding which is consistent with the findings of the laboratory studies. Thus if all cases which were immunofluorescence-positive in the clinical study were in fact chancroid, the sensitivity of the isolation technique employed could be accurately assessed as 82% for ulcers and 42% for bubos. These figures are in agreement with previous studies where investigators have failed to isolate H. ducreyi from approximately 19% of primary lesions which were Karim, Finn, Easmon, Dangor, Dance, Ngeow, Ballard clinically diagnosed as chancroid and from a higher proportion of bubos.9 Unfortunately in neither of the series was a complete range of diagnostic tests undertaken to exclude other aetiologies and thus to determine the absolute specificity of the immunofluorescence test. A comprehensive microbiological study employing microscopic, culture and serological techniques to exclude all possible differential diagnoses and thus determine accurately the specificity of the test is currently in progress.
Unfortunately, the subjective nature of immunofluorescence tests and the need for an expensive immunofluorescence microscope preclude the use of the test in many peripheral clinics where chancroid is endemic, but tests could easily be performed at regional reference centres. However, in the absence of culture facilities, the test can be used to determine whether chancroid is a significant cause of genital ulcer disease in developing societies (prevalence studies) and could also prove a valuable research tool in studies on the pathogenesis and epidemiology ofthe disease. Even in this limited evaluation, the results obtained from the Malaysian specimens indicate that chancroid is a significant cause of genital ulcer disease in that country. This conclusion was reached despite the specimens being sent to London by mail and arriving three months after collection. Meanwhile, it is clear that further development of diagnostic tests using monoclonal antibodies should be investigated, such as ELISA and immunoblotting. 
